Approval · Notice of Compliance 2997 · 1998
IPRATROVENT STERULES: Notice of Compliance 2997
Issued January 28, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2997
- Date
- January 28, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- New dosage form: sterules
- Therapeutic class
- Bronchodilator
- Canadian reference product
- ATROVENT INHALATION SOLUTION
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPRATROVENT STERULES | 02237189 | — |
Medicinal ingredients
- IPRATROPIUM BROMIDE 250 MCG per ML